Fovia hires Sandy as VP of business development

TriMed Staff | | Health Imaging | Artificial Intelligence
Steve Sandy has joined Fovia, a provider of volume rendering technology, as vice president of business development. 

The Palo Alto, Calif.-based company said that Sandy brings more than 25 years experience as a senior business development and marketing executive. For the past seven years, Sandy was vice president of marketing at TeraRecon. Prior to TeraRecon, he was a co-founder and vice president of business development for Real Time Visualization, the developer of a 3D real-time volume rendering application-specific integrated circuit, Fovia said.

“His understanding of the 3D-imaging market coupled with his technological and clinical experience will be invaluable to the continuing development and commercialization of our technology,” said Ken Fineman, Fovia’s president and CEO.

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.